îæ€çŽ¢
îæ€çŽ¢
î
F/m Emerald Life Sciences Innovation ETF
LFSCîãŠã©ãããªã¹ãã«è¿œå
44.904USD
+1.658+3.83%
çµå€Â 11-06 16:00ïŒETïŒ
0.00åºæ¥é«
0.00売買代é
æ¬æ¥
+3.83%
5æ¥é
+3.00%
1ã¶æ
+7.33%
6ã¶æ
+16.97%
幎åæ¥
+22.64%
1幎é
+42.15%
äž»èŠããŒã¿
43.569å§å€
43.246åæ¥çµå€
44.904é«å€
43.569å®å€
0.00åºæ¥é«
0売買代é
0.31åºæ¥é«æ¯ç%
48.78052é±é«å€
32.84052é±å®å€
2.71Kå¹³ååºæ¥é«
--é
åœå©åã
--äºæ³å¹Žéé
åœ
Health Careæè³åé
ãããã€ã³ããŒã¹åETF
ãããã¬ãã¬ããžETF
--ã¬ãã¬ããžåç
41.515åºæºäŸ¡é¡ïŒNAVïŒ
USDåºæºäŸ¡é¡é貚
6.27PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
--æ ªäŸ¡åççïŒP/EïŒ
F/m Emerald Life Sciences Innovation ETF ãããã£ãŒã«
äŒæ¥ã³ãŒãLFSC
è³ç£ã¯ã©ã¹Equity
ãã¡ã³ããããŒãžã£ãŒF/m
èšå®åœUS
çµè²»ç0.54%
èšç«æ¥2024-10-30
ãŠã§ããµã€ãhttps://www.fminvest.com/
é£å察象ææ°--
LFSC was created on 2024-10-30 by F/m. The fund's investment portfolio concentrates primarily on health care equity. LFSC is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities.
äžäœ10ä¿æéæ
No.販売å称
äŸ¡æ Œ
å€åã
å€åç%
ä¿ææ ªåŒæ°
ãŠã§ã€ã
æ䟡ç·é¡
ãŠã©ãããªã¹ã
LivaNova PLC
LIVN
89.990
-1.150
-1.26%
105.38K
6.99%
$8.56M
î
Replimune Group Inc
REPL
21.620
+1.600
+7.99%
620.24K
6.07%
$7.44M
î
Corcept Therapeutics Inc
CORT
72.770
+1.140
+1.59%
69.01K
6.05%
$7.42M
î
4
Cogent Biosciences Inc
COGT
31.645
+2.065
+6.98%
235.47K
6.02%
$7.37M
î
5
Travere Therapeutics Inc Ordinary Shares
TVTX
49.600
+0.730
+1.49%
140.25K
6.00%
$7.35M
î
6
Spyre Therapeutics Inc
SYRE
103.860
+7.270
+7.53%
71.48K
5.39%
$6.60M
î
7
Guardant Health Inc
GH
150.870
-2.560
-1.67%
37.72K
5.02%
$6.15M
î
8
BillionToOne Inc Ordinary Shares - Class A
BLLN
113.940
+1.550
+1.38%
54.12K
4.67%
$5.72M
î
9
Veradermics Inc
MANE
138.780
+10.180
+7.92%
37.03K
4.19%
$5.13M
î
10
United Therapeutics Corp
UTHR
562.020
-3.700
-0.65%
8.04K
3.84%
$4.70M
î
F/m Emerald Life Sciences Innovation ETF ãã¯ãã«ã«åæ
ãã¯ãã«ã«ææš
売ã
èŠçŽ
è²·ã
移åå¹³å
匷åè²·ãæšå¥š
F/m Emerald Life Sciences Innovation ETF ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
人æ°éæ
î
51290.600
-208.500Â (-0.41%)
26964.500
+329.300Â (+1.24%)
7380.000
+23.100Â (+0.31%)
12797.000
-1.000Â (-0.01%)
58142.000
+876.000Â (+1.53%)
6140.600
-37.200Â (-0.60%)
89.857
-0.176Â (-0.20%)
342.370
-1.800Â (-0.52%)
186.640
+5.040Â (+2.78%)
4065.670
-33.020Â (-0.81%)
ãããã質å
F/M Emerald Life Sciences Innovation ETFïŒLFSCïŒã®çŸåšã®äŸ¡æ Œã¯ãããã§ããïŒ
îF/M Emerald Life Sciences Innovation ETFïŒLFSCïŒã®çŸåšäŸ¡æ Œã¯44.90ã§ããåžå ŽããŒã¿ã«ã¯é
延ãçããå ŽåããããããããŒãžäžã«è¡šç€ºãããŠããæŽæ°æ¥æããåç
§ãã ããã
F/M Emerald Life Sciences Innovation ETFã®52é±é«å€ã¯ãããã§ããïŒ
îF/M Emerald Life Sciences Innovation ETFã®52é±é«å€ã¯48.78ã§ããææ°ããŒã¿ã«ã€ããŠã¯ãããŒãžã«è¡šç€ºãããŠããæŽæ°æ¥æãã確èªãã ããã
F/M Emerald Life Sciences Innovation ETFã®52é±å®å€ã¯ãããã§ããïŒ
îF/M Emerald Life Sciences Innovation ETFã®52é±å®å€ã¯32.84ã§ããææ°ããŒã¿ã«ã€ããŠã¯ãããŒãžã«è¡šç€ºãããŠããæŽæ°æ¥æãã確èªãã ããã
F/M Emerald Life Sciences Innovation ETFã®NAVïŒçŽè³ç£äŸ¡å€ïŒã¯ãããã§ããïŒ
îæ¬æ¥ã®F/M Emerald Life Sciences Innovation ETFã®NAVã¯41.52ã§ããNAVã¯ãã¡ã³ãã®ç·è³ç£ããè² åµãå·®ãåŒããçŽè³ç£ãè¡šãã1å£ãããã®æ¬è³ªç䟡å€ã瀺ãææšãšãªããŸãã
F/M Emerald Life Sciences Innovation ETFïŒLFSCïŒãžã®æè³ã¯å®å šã§ããïŒ
îå®å
šã«ãªã¹ã¯ã®ãªãæè³ã¯ååšããŸãããF/M Emerald Life Sciences Innovation ETFïŒLFSCïŒã®ãªã¹ã¯ã¬ãã«ã¯ããã®åè³ç£ãæŠç¥ãæµåæ§ãææ°æãããã³åžå Žç°å¢ã«ãã£ãŠç°ãªããŸããåæ£æè³ã«ããæœåšçãªæ倱ã軜æžã§ããå ŽåããããŸããããªã¹ã¯ãå®å
šã«æé€ããããšã¯ã§ãããéå»ã®å®çžŸã¯å°æ¥ã®ææãä¿èšŒãããã®ã§ã¯ãããŸãããæè³ãè¡ãåã«ãåœè©²ãã¡ã³ãããèªèº«ã®ç®æšããªã¹ã¯èš±å®¹åºŠã«åèŽããŠãããããæ€èšãã ãããæ¬å
容ã¯æè³å©èšãæ§æãããã®ã§ã¯ãããŸããã